| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥522.2B | ¥531.4B | -1.7% |
| Operating Income | ¥171.2B | ¥197.3B | -13.2% |
| Ordinary Income | ¥180.3B | ¥200.3B | -10.0% |
| Net Income | ¥123.3B | ¥139.7B | -11.7% |
| ROE | 8.8% | 10.9% | - |
FY2026 Q3 results show revenue of 522.2B yen (YoY -1.7%) with operating income of 171.2B yen (YoY -13.2%), ordinary income of 180.3B yen (YoY -10.0%), and net income of 123.3B yen (YoY -11.7%). The company faced margin compression despite maintaining high absolute profitability, with gross profit margin declining 280bp to 51.6% and operating margin contracting 430bp to 32.8%. Non-operating income of approximately 9.1B yen, primarily from interest income of 4.0B yen and foreign exchange gains of 3.6B yen, partially offset operating profit declines. Total assets expanded to 1,526.7B yen from 1,422.8B yen, driven by a 27.4% increase in property, plant and equipment to 501.5B yen, with construction-in-progress reaching 135.4B yen representing 27% of tangible fixed assets. The company maintains an exceptionally strong balance sheet with net cash position and equity ratio of 92.2%, though working capital efficiency deteriorated with cash conversion cycle extending to 243 days.
[Profitability] ROE of 8.8% remains below optimal range of 10-15% and represents deterioration from prior year levels, driven by asset turnover decline from 0.373 to 0.342 and operating margin compression from 37.1% to 32.8%. Net profit margin of 23.6% decreased 270bp from 26.3% YoY, while gross margin contracted 280bp to 51.6%. SG&A expenses increased 7.4% to 98.5B yen, raising SG&A ratio 160bp to 18.9%, indicating operating leverage working in reverse as cost growth outpaced revenue. ROA of 8.1% and ROIC of approximately 9.5% reflect reduced capital efficiency amid large-scale investment expansion. [Cash Quality] Cash and deposits of 678.4B yen provide 6.0x coverage of short-term liabilities of 113.1B yen. Days sales outstanding of 97 days and days inventory outstanding of 207 days result in cash conversion cycle of 243 days, indicating significant working capital absorption. Accounts receivable of 141.8B yen and inventories of 143.4B yen represent substantial current assets, though inventory composition shows raw materials of 69.4B yen and work-in-progress of 48.8B yen suggesting production buildup. [Investment Efficiency] Asset turnover of 0.342 declined from 0.373, primarily due to total assets expanding 7.3% to 1,526.7B yen while revenue contracted 1.7%. Construction-in-progress of 135.4B yen represents ongoing capacity expansion investments yet to contribute to revenue generation. Fixed asset turnover metrics are suppressed by the 27.4% increase in tangible fixed assets. [Financial Health] Equity ratio of 92.2% increased from 89.9%, current ratio of 890.6%, quick ratio of 868.2%, and debt-to-equity ratio of 0.08 all indicate exceptional financial stability. Total liabilities of only 118.4B yen against equity of 1,408.4B yen demonstrate virtually debt-free capital structure. Retained earnings increased 111.2B yen or 10.5% to 1,169.8B yen despite dividend payments, maintaining robust capital accumulation.
Cash and deposits increased 70.3B yen YoY to 678.4B yen, reflecting strong underlying cash generation despite margin pressure. The increase in accounts payable of 12.4B yen or 41.9% to 42.1B yen indicates active production and procurement activities with effective supplier credit utilization. Working capital movements show accounts receivable expanding alongside inventory buildup, with total inventories at 143.4B yen representing significant capital tied in operations, though partially offset by payables growth. Construction-in-progress of 135.4B yen signals substantial ongoing capital investments in capacity expansion and advanced manufacturing capabilities. The 27.4% increase in tangible fixed assets to 501.5B yen demonstrates execution of long-term investment plans. Cash coverage of short-term liabilities stands at 6.0x, indicating more than adequate liquidity to meet all near-term obligations. The combination of strong cash position and minimal debt provides substantial financial flexibility for continued investments while maintaining dividend capacity. Retained earnings growth of 111.2B yen confirms profit-driven capital accumulation even after distributions.
Ordinary income of 180.3B yen versus operating income of 171.2B yen shows non-operating net contribution of approximately 9.1B yen, comprising primarily interest income of 4.0B yen and foreign exchange gains of 3.6B yen. Non-operating income represents 1.7% of revenue, with financial income stemming from the company's substantial cash holdings of 678.4B yen generating consistent interest returns. The 3.6B yen foreign exchange gain introduces some earnings volatility given its non-recurring nature. Special items totaled 1.0B yen compared to 12.6B yen in prior year which included government subsidies, indicating the current period reflects more normalized core operations without significant one-time benefits. The margin compression at operating level from 37.1% to 32.8% suggests pressure on core business profitability through either pricing headwinds, product mix shifts toward lower-margin items, or manufacturing inefficiencies during production ramp-up phases. SG&A expenses growing 7.4% while revenue declined 1.7% indicates fixed cost deleverage requiring attention. The cash conversion cycle of 243 days with elevated inventory and receivables levels suggests potential timing differences between revenue recognition and cash realization, warranting monitoring of actual cash collection patterns against reported profits.
Working capital deterioration poses near-term cash flow risk, with days inventory outstanding of 207 days and days sales outstanding of 97 days combining for a 243-day cash conversion cycle, substantially higher than the industry median of 108 days, indicating significant capital tied up in operations that could pressure operating cash flow generation despite reported profits. Margin compression of 430bp in operating margin from 37.1% to 32.8% driven by gross margin decline of 280bp and SG&A ratio increase of 160bp signals vulnerability to pricing pressure, unfavorable product mix, or production inefficiencies that require resolution to restore profitability trajectory. Large-scale investment execution risk is evident with construction-in-progress of 135.4B yen representing 27% of total tangible fixed assets, creating exposure to ramp-up challenges, yield issues, demand timing mismatches, or potential asset impairment if capacity expansion does not achieve expected returns.
[Industry Position] (Reference - Proprietary Analysis) Profitability metrics significantly exceed industry norms, with operating margin of 32.8% versus manufacturing industry median of 8.3%, net profit margin of 23.6% versus industry median of 6.3%, and ROE of 8.8% versus industry median of 5.0%, confirming MARUWA's premium market position in specialized ceramic components despite recent margin pressure. Financial health indicators also surpass peers substantially, with equity ratio of 92.2% versus industry median of 63.8% and current ratio of 890.6x versus industry median of 2.84x, reflecting conservative capital structure. Asset turnover of 0.342 falls below industry median of 0.58, indicating lower asset utilization partly due to ongoing large-scale investments. Working capital efficiency shows room for improvement, with operating working capital days significantly above industry norms and inventory turnover of 207 days well above industry median of 109 days. Revenue decline of -1.7% contrasts with industry median growth of +2.7%, though this reflects near-term cyclical factors rather than structural competitiveness given the company's strong profitability maintenance. (※ Industry: Manufacturing sector, 2025-Q3 reference period, Source: Proprietary analysis)
Exceptional profitability and financial strength provide substantial strategic flexibility, with operating margin of 32.8% and net profit margin of 23.6% remaining multiples above industry averages despite recent compression, while the debt-free balance sheet with 678.4B yen cash and 92.2% equity ratio enables sustained investment in growth initiatives and shareholder returns even through cyclical challenges. Working capital management and capacity ramp-up execution emerge as critical near-term value drivers, as the 243-day cash conversion cycle and 135.4B yen construction-in-progress create both risk and opportunity depending on management's ability to compress operating working capital through inventory optimization and receivables collection while successfully commissioning new production assets to restore margin trajectory and revenue growth. Full-year guidance achievement requires significant Q4 acceleration, with approximately 229B yen revenue and 99B yen operating income needed in the fourth quarter versus Q3 run-rate of roughly 174B yen and 57B yen respectively, suggesting either expected seasonal strength, new product launches, or capacity coming online that investors should monitor closely for execution validation.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.